Universal
Universal's revenue fell 1.3% to $2.9 billion in fiscal 2026. Its operating margin was 5.8%, down from 8.0% a year earlier. Free cash flow was $80 million, down 69.6%. It paid out $81 million in dividends and buybacks, 101% of free cash flow. The diluted share count rose 0.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2017 to 2026, earnings per share grew 4.4% a year and net income fell 12.3% a year, as new shares raised the share count by 6% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Universal yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Universal's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Universal's fiscal 2026 free cash flow of $80M, net cash of −$842M at March 31, 2026 and 25 million diluted shares, from its filings. The scenarios are fitted to Universal: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 4.2% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 8%: 7% for a stable business (Tobacco), plus 1 point as a smaller company, worth $978M; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $38.96
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Universal's earnings per share of $0.76 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 29.5×, the middle of Universal's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 9%, 8% and 7%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $38.96
- Value at this multiple, against the last close
- —
- Universal's P/E at the last close
- 51.3×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| UniversalUVV | $38.96 | $0.76 | 51.3× |
| Cal-Maine FoodsCALM | $62.32 | $1.22 | 51.1× |
| Philip Morris InternationalPM | $201.87 | $6.85 | 29.5× |
| AltriaMO | $73.62 | $4.75 | 15.5× |
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 82 | 65 | 56 | 260 | 62 |
| Debt incl. finance leases | 701 | 812 | 1,035 | 1,073 | 904 |
| Net debt (negative means net cash) | 620 | 748 | 979 | 813 | 842 |
| Net debt to EBITDA | 2.9x | 3.1x | 3.5x | 2.8x | 3.8x |
| Debt to equity | 0.5x | 0.6x | 0.7x | 0.7x | 0.6x |
| Interest coverage | 5.8x | 3.7x | 3.4x | 2.9x | 2.3x |
| Current ratio | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
| Quick ratio | 3.4x | 4.1x | 3.0x | 2.9x | 3.5x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Universal shares on the open market, and 2 insiders sold $496,953.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Lennart R. FreemanDirector | Sold | 1,782 | $49.82 | $88,779 | Form 4 |
| Jun 3, 2026 | Robert C SleddDirector | Sold | 2,845 | $54.13 | $154,000 | Form 4 |
| Feb 26, 2026 | Robert C SleddDirector | Sold | 1,000 | $53.95 | $53,950 | Form 4 |
| Feb 19, 2026 | Lennart R. FreemanDirector | Sold | 3,746 | $53.45 | $200,224 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Fail | Pass | Pass |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Fail | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Fail |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | 3 of 9 | 4 of 9 | 5 of 9 |
| Accruals ratio | 7.0% | −7.8% | −3.4% |
Compare
Put Universal side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Universal | FY26 | −1.3% | 5.8% | 2.8% | 4.0% | 3.8x | 5 | |
| Altria | FY25 | −3.1% | 42.5% | 39.0% | 39.2% | 2.1x | 7 | Compare |
| British American Tobacco | FY25 | −1.0% | 39.0% | 22.6% | 9.8% | — | 6 | Compare |
| Philip Morris International | FY25 | 7.3% | 36.6% | 26.2% | 35.4% | 2.6x | 7 | Compare |
| Cal-Maine Foods | FY26 | −31.7% | 12.0% | 11.3% | — | — | — | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 2,047 | 2,019 | 2,213 | 1,892 | 1,966 | 2,091 | 2,550 | 2,722 | 2,923 | 2,885 |
| Revenue growth | −3.4% | −1.4% | 9.6% | −14.5% | 3.9% | 6.4% | 21.9% | 6.7% | 7.4% | −1.3% |
| Gross profit | 371 | 357 | 393 | 339 | 368 | 396 | 438 | 509 | 524 | 473 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 178 | 171 | 161 | 126 | 148 | 160 | 181 | 222 | 233 | 168 |
| Net income | 106 | 106 | 104 | 72 | 87 | 87 | 124 | 120 | 95 | 33 |
| Diluted EPS (US$) | 0.88 | 4.14 | 4.11 | 2.86 | 3.53 | 3.47 | 4.97 | 4.78 | 3.78 | 1.30 |
| Diluted shares (millions) | 24 | 26 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Cash flow | ||||||||||
| Cash from operations | 250 | 81 | 164 | 11 | 220 | 45 | −11 | −75 | 327 | 129 |
| Capital expenditure | 36 | 34 | 39 | 35 | 66 | 53 | 55 | 66 | 63 | 49 |
| Free cash flow | 215 | 47 | 126 | −24 | 154 | −8 | −65 | −141 | 264 | 80 |
| Dividends paid | 50 | 55 | 70 | 75 | 75 | 76 | 77 | 78 | 80 | 81 |
| Share buybacks | 0 | 22 | 1 | 34 | 0 | 3 | 3 | 5 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 80 | 162 | 102 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 6 | 8 | 8 | 6 | 6 | 6 | 8 | 12 | 8 | 7 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 284 | 234 | 298 | 107 | 197 | 82 | 65 | 56 | 260 | 62 |
| Debt incl. finance leases | 429 | 415 | 424 | 447 | 620 | 701 | 812 | 1,035 | 1,073 | 904 |
| Total assets | 2,123 | 2,169 | 2,133 | 2,121 | 2,342 | 2,586 | 2,639 | 2,937 | 2,990 | 2,767 |
| Total liabilities | 797 | 783 | 753 | 832 | 994 | 1,202 | 1,202 | 1,458 | 1,489 | 1,306 |
| Shareholders' equity | 1,286 | 1,342 | 1,337 | 1,247 | 1,307 | 1,340 | 1,397 | 1,437 | 1,459 | 1,415 |
| Margins and ratios | ||||||||||
| Gross margin | 18.1% | 17.7% | 17.7% | 17.9% | 18.7% | 19.0% | 17.2% | 18.7% | 17.9% | 16.4% |
| Operating margin | 8.7% | 8.5% | 7.3% | 6.7% | 7.5% | 7.7% | 7.1% | 8.2% | 8.0% | 5.8% |
| Net margin | 5.2% | 5.2% | 4.7% | 3.8% | 4.5% | 4.1% | 4.9% | 4.4% | 3.2% | 1.1% |
| Free cash flow margin | 10.5% | 2.3% | 5.7% | −1.3% | 7.8% | −0.4% | −2.6% | −5.2% | 9.0% | 2.8% |
| Return on capital | 7.8% | 7.8% | 7.6% | 5.5% | 6.7% | 6.2% | 7.9% | 7.8% | 7.2% | 4.0% |
| Return on equity | 7.9% | 8.0% | 7.8% | 5.5% | 6.8% | 6.5% | 9.1% | 8.4% | 6.6% | 2.3% |
| Return on assets | 4.9% | 4.9% | 4.8% | 3.4% | 3.9% | 3.5% | 4.8% | 4.3% | 3.2% | 1.1% |
| Net debt to EBITDA | 0.7x | 0.9x | 0.6x | 2.1x | 2.2x | 2.9x | 3.1x | 3.5x | 2.8x | 3.8x |